Clinical Trial Update: Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the duration of metabolic effect after a single subcutaneous dose of Lantus (insulin glargine) versus NPH insulin in adults with Type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED